313 related articles for article (PubMed ID: 25130328)
1. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.
Santana-de Anda K; Gómez-Martín D; Monsivais-Urenda AE; Salgado-Bustamante M; González-Amaro R; Alcocer-Varela J
Clin Exp Immunol; 2014 Dec; 178(3):428-37. PubMed ID: 25130328
[TBL] [Abstract][Full Text] [Related]
2. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
Niewold TB; Kelly JA; Kariuki SN; Franek BS; Kumar AA; Kaufman KM; Thomas K; Walker D; Kamp S; Frost JM; Wong AK; Merrill JT; Alarcón-Riquelme ME; Tikly M; Ramsey-Goldman R; Reveille JD; Petri MA; Edberg JC; Kimberly RP; Alarcón GS; Kamen DL; Gilkeson GS; Vyse TJ; James JA; Gaffney PM; Moser KL; Crow MK; Harley JB
Ann Rheum Dis; 2012 Mar; 71(3):463-8. PubMed ID: 22088620
[TBL] [Abstract][Full Text] [Related]
3. The
Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
[TBL] [Abstract][Full Text] [Related]
4. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
5. Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus.
Akahoshi M; Nakashima H; Sadanaga A; Miyake K; Obara K; Tamari M; Hirota T; Matsuda A; Shirakawa T
Lupus; 2008 Jun; 17(6):568-74. PubMed ID: 18539711
[TBL] [Abstract][Full Text] [Related]
6. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.
Feng D; Stone RC; Eloranta ML; Sangster-Guity N; Nordmark G; Sigurdsson S; Wang C; Alm G; Syvänen AC; Rönnblom L; Barnes BJ
Arthritis Rheum; 2010 Feb; 62(2):562-73. PubMed ID: 20112383
[TBL] [Abstract][Full Text] [Related]
8. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus.
Sánchez E; González-Gay MA; Callejas-Rubio JL; Ortego-Centeno N; Sabio JM; Jiménez-Alonso J; Micó L; Suarez A; Gutierrez C; de Ramón E; Camps M; Garcia-Portales R; Tolosa C; López-Nevot MA; Sánchez-Román J; Hernández FJ; González-Escribano MF; Martín J
Lupus; 2009 Mar; 18(3):230-4. PubMed ID: 19213861
[TBL] [Abstract][Full Text] [Related]
9. IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.
Berggren O; Alexsson A; Morris DL; Tandre K; Weber G; Vyse TJ; Syvänen AC; Rönnblom L; Eloranta ML
Hum Mol Genet; 2015 Jun; 24(12):3571-81. PubMed ID: 25779693
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
11. Anti-interferon alpha treatment in SLE.
Kirou KA; Gkrouzman E
Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
[TBL] [Abstract][Full Text] [Related]
12. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
Matta B; Barnes BJ
Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
[TBL] [Abstract][Full Text] [Related]
13. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production.
Chung SA; Taylor KE; Graham RR; Nititham J; Lee AT; Ortmann WA; Jacob CO; Alarcón-Riquelme ME; Tsao BP; Harley JB; Gaffney PM; Moser KL; ; Petri M; Demirci FY; Kamboh MI; Manzi S; Gregersen PK; Langefeld CD; Behrens TW; Criswell LA
PLoS Genet; 2011 Mar; 7(3):e1001323. PubMed ID: 21408207
[TBL] [Abstract][Full Text] [Related]
14. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
15. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH; Ling P; Liu MF
J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
[TBL] [Abstract][Full Text] [Related]
16. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
18. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.
Kawasaki A; Kyogoku C; Ohashi J; Miyashita R; Hikami K; Kusaoi M; Tokunaga K; Takasaki Y; Hashimoto H; Behrens TW; Tsuchiya N
Arthritis Rheum; 2008 Mar; 58(3):826-34. PubMed ID: 18311811
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor 5 gene polymorphism in Egyptian children with systemic lupus erythematosus.
Hammad A; Mossad YM; Nasef N; Eid R
Lupus; 2017 Jul; 26(8):871-880. PubMed ID: 28059021
[TBL] [Abstract][Full Text] [Related]
20. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
